adenosine monophosphate has been researched along with Cancer of Endometrium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Gu, Y; Li, W; Liu, S; Lv, W; Ruan, F | 1 |
Feng, ZH; Liu, LZ; Zhang, Y; Zhu, XX | 1 |
Huez, G; Kruys, V; Pasté, M | 1 |
3 other study(ies) available for adenosine monophosphate and Cancer of Endometrium
Article | Year |
---|---|
GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway.
Topics: Adenosine Monophosphate; Animals; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Endometrial Neoplasms; Female; Glucagon-Like Peptide-1 Receptor; Humans; Mice; RNA, Messenger; RNA, Small Interfering | 2022 |
Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5'-monophosphate (AMP)-activated protein kinase signaling pathway.
Topics: Adenosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Liraglutide; Phosphorylation; Protein Kinases; Signal Transduction | 2021 |
Deadenylation of interferon-beta mRNA is mediated by both the AU-rich element in the 3'-untranslated region and an instability sequence in the coding region.
Topics: 3' Untranslated Regions; Adenocarcinoma; Adenosine Monophosphate; Endometrial Neoplasms; Female; Humans; Interferon-beta; Open Reading Frames; Respirovirus Infections; Response Elements; RNA Stability; RNA, Messenger; Sendai virus; Tumor Cells, Cultured | 2003 |